JOAN BRUNSON: Open Payments
NPI 1184616112 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 105 payments from 23 companies in 2025. Trend: 2023 $1,997 · 2024 $2,020 · 2025 $1,896
Food & beverage: $1,896
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $418 |
| Otsuka America Pharmaceutical, Inc. | 8 | $189 |
| Novo Nordisk Inc | 12 | $183 |
| Axsome Therapeutics, Inc. | 8 | $175 |
| AstraZeneca Pharmaceuticals LP | 8 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $138 |
| GlaxoSmithKline, LLC. | 7 | $122 |
| Exact Sciences Corporation | 3 | $62 |
| PFIZER INC. | 3 | $62 |
| Lilly USA, LLC | 4 | $60 |
Products named: QULIPTA, REXULTI, Auvelity, FARXIGA, JARDIANCE, TRELEGY ELLIPTA, VRAYLAR, Rybelsus.
Industry payments across LA — which companies pay providers there.
